CIPLANSECipla Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Tue, 13 May, 2025 · 13:44 IST

Cipla Limited has informed the Exchange that Board of Directors at its meeting held on May 13, 2025, recommended Final Dividend of Rs. 16 per equity share.

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.8%Reaction day
₹1507.30
prior close
₹1504.80
announcement price
In-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)-1.2%+2.0% vs market
Pharmaceuticals peers, median of 149sector+0.9%-0.0% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty 100 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.9
15m
+0.8
30m
+0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.8-1.2+2.0+0.9-0.0
Next day
-0.5-0.7+0.3+2.0-2.5
2d
-0.4+0.8-1.2+2.4-2.9
3d
-0.4+0.8-1.3+3.2-3.6
4d
-1.1+0.7-1.8+3.8-4.9
5d
-3.5-0.5-3.0+3.5-7.0
1w
-3.1-0.6-2.4+3.6-6.7
15d
-2.4-0.9-1.5+4.0-6.4
1m
+0.0-0.2+0.2+5.9-5.9
2m
-1.6+1.4-3.0+7.4-9.0
3m
+3.5-0.6+4.1+3.0+0.5
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Cipla's Board has recommended a total dividend of Rs. 16 per equity share for FY25, comprising a regular final dividend of Rs. 13 plus a one-time special dividend of Rs. 3 to mark the company's 90th anniversary. The record date is fixed as June 27, 2025, subject to shareholder approval at the AGM. For FY25, consolidated revenue from operations grew about 6.9% to Rs. 27,547 crores, while net profit jumped roughly 27% to Rs. 5,269 crores. Q4 FY25 (standalone) was also strong, with standalone revenue at Rs. 4,797 crores and net profit of Rs. 1,485 crores. Basic EPS for the full year rose to Rs. 65.29 from Rs. 51.05 in the prior year. The auditors (Walker Chandiok & Co LLP) gave an unmodified opinion on the results.

Likely market impact

Healthy profit growth and a celebratory special dividend are positive for shareholders, though the regular Rs. 13 dividend is unchanged from last year, so this is more of a stable payout with a bonus than a major hike. The stock may see mild positive sentiment around the record date, but no dramatic rerating is expected from the dividend alone.